Combination Cancer Therapy Modulators and Potentiators /

Early clinical trials of the new molecular-based anticancer agents have shown that many are marginal in controlling cancer, but prove to be potent modulators and potentiators of chemotherapy-induced apoptosis when used in combination with classic cytotoxic drugs or radiation. In Combination Cancer T...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Schwartz, Gary K. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Totowa, NJ : Humana Press, 2005.
Σειρά:Cancer Drug Discovery and Development
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Targeting of the EGFR As a Modulator of Cancer Chemotherapy
  • Cyclin-Dependent Kinase Inhibitors in Combination Chemotherapy
  • Development of Protein Kinase C and Cyclin-Dependent Kinase Inhibitors As Potentiators of Cytotoxic Drug Action in Leukemia
  • Carboxyamidotriazole, an Inhibitor of Nonvoltage-Operated Calcium Entry
  • Targeted ?-Particle Therapy
  • Pharmacological Modulation of Fluoropyrimidines
  • Development of Inhibitors of HER2 With Taxanes
  • Targeting NF-?B to Increase the Activity of Cisplatin in Solid Tumors
  • Combinations of Chemotherapy and G3139, an Antisense Bcl-2 Oligonucleotide
  • Use of Animal Models to Evaluate Signal Transduction Inhibitors As Modulators of Cytotoxic Therapy.